We are live on ! Find out more
SLG

Stanley-Laman Group Portfolio holdings

AUM $984M
1-Year Est. Return 72.08%
This Fund
S&P 500
This Quarter Est. Return
+0.91%
1 Year Est. Return
+72.08%
3 Year Est. Return
+124.02%
5 Year Est. Return
+117.81%
10 Year Est. Return
+397.76%
AUM
$405M
AUM Growth
-$11.8M
Cap. Flow
-$9.04M
Cap. Flow %
-2.23%
Top 10 Hldgs %
15.35%
Holding
294
New
21
Increased
45
Reduced
123
Closed
29

Sector Composition

Rank Sector Weight
1 Technology 20.64%
2 Industrials 16.97%
3 Miscellaneous 14.64%
4 Healthcare 12.55%
5 Consumer Discretionary 8.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
76
CVS Health
CVS
$124B
$1.4M 0.35%
22,224
-235
-1% -$13.9K
MIME
77
DELISTED
Mimecast Limited
MIME
$1.38M 0.34%
38,572
+5,717
+17% +$249K
NOC icon
78
Northrop Grumman
NOC
$73.2B
$1.38M 0.34%
3,669
-297
-7% -$105K
LDOS icon
79
Leidos
LDOS
$16.7B
$1.37M 0.34%
15,921
-1,347
-8% -$113K
SJM icon
80
J.M. Smucker
SJM
$13.5B
$1.36M 0.34%
12,346
-1,328
-10% -$148K
EGRX
81
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$1.36M 0.34%
24,000
TTEK icon
82
Tetra Tech
TTEK
$9.19B
$1.31M 0.32%
75,645
+185
+0.2% +$3.02K
MRK icon
83
Merck
MRK
$371B
$1.28M 0.32%
15,913
-1,381
-8% -$111K
ENTG icon
84
Entegris
ENTG
$21.2B
$1.27M 0.31%
26,976
-316
-1% -$13.3K
DIS icon
85
Walt Disney
DIS
$182B
$1.27M 0.31%
9,727
-741
-7% -$102K
MDT icon
86
Medtronic
MDT
$120B
$1.26M 0.31%
11,616
-902
-7% -$94.1K
MET icon
87
MetLife
MET
$62B
$1.26M 0.31%
26,760
KNSL icon
88
Kinsale Capital Group
KNSL
$8.5B
$1.23M 0.3%
11,938
+73
+0.6% +$7K
AKBA icon
89
Akebia Therapeutics
AKBA
$270M
$1.23M 0.3%
312,609
EVRG icon
90
Evergy
EVRG
$18.8B
$1.22M 0.3%
18,279
-1,498
-8% -$94.8K
TMHC
91
DELISTED
Taylor Morrison
TMHC
$1.2M 0.3%
46,272
-3,602
-7% -$83K
NDAQ icon
92
Nasdaq
NDAQ
$54.2B
$1.2M 0.3%
36,147
-3,225
-8% -$107K
UNH icon
93
UnitedHealth
UNH
$356B
$1.2M 0.3%
5,509
-381
-6% -$91.9K
NTAP icon
94
NetApp
NTAP
$36.5B
$1.18M 0.29%
22,410
+1,169
+6% +$62.7K
EXP icon
95
Eagle Materials
EXP
$5.97B
$1.16M 0.29%
12,901
-7
-0.1% -$601
ECL icon
96
Ecolab
ECL
$78.3B
$1.16M 0.29%
5,847
-567
-9% -$114K
CMCSA icon
97
Comcast
CMCSA
$94B
$1.16M 0.29%
25,639
-1,818
-7% -$80.5K
ORCL icon
98
Oracle
ORCL
$457B
$1.16M 0.29%
20,990
-1,617
-7% -$89.3K
ABBV icon
99
AbbVie
ABBV
$453B
$1.15M 0.28%
15,246
-192
-1% -$13.2K
CCMP
100
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$1.15M 0.28%
8,139
-2,475
-23% -$305K

Similar funds

Stanley-Laman Group's Q3 2019 Portfolio in Review

As of Q3 2019, Stanley-Laman Group held 294 positions worth $405M, down 2.8% from $417M the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Stanley-Laman Group's Q3 2019 filing shows 21 new, 45 increased, 123 reduced and 29 closed positions. Its largest new stake was ZENDESK INC: 4,885 shares worth $356K. The largest sale was L3 Technologies, Inc., an estimated $1.37M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Industrials and Miscellaneous.

  • Stanley-Laman Group's largest Q3 2019 buy was ZENDESK INC: 4,885 shares worth $356K.
  • Stanley-Laman Group added most to L3Harris in Q3 2019, an estimated $1.32M increase.
  • Stanley-Laman Group's biggest Q3 2019 reduction was Rekor Systems, cutting an estimated $632K.
  • Stanley-Laman Group fully exited L3 Technologies, Inc. in Q3 2019, selling an estimated $1.37M.
  • Stanley-Laman Group's ten largest holdings make up 15% of its $405M portfolio in Q3 2019.
  • Stanley-Laman Group opened 21 new positions and closed 29 in Q3 2019.
  • Stanley-Laman Group's portfolio value fell 2.8% quarter-over-quarter to $405M.

Based on Stanley-Laman Group's 13F filing for Q3 2019, filed 8 Nov 2019.